Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Calculi | 76 | 2024 | 458 | 16.750 |
Why?
|
Hearing Loss | 26 | 2024 | 785 | 7.210 |
Why?
|
Uric Acid | 36 | 2024 | 805 | 4.570 |
Why?
|
Gout | 32 | 2024 | 620 | 4.190 |
Why?
|
Hypertension | 75 | 2024 | 8615 | 3.050 |
Why?
|
Oxalates | 14 | 2024 | 99 | 2.850 |
Why?
|
Albuminuria | 21 | 2018 | 658 | 2.720 |
Why?
|
Nephrolithiasis | 10 | 2024 | 117 | 2.530 |
Why?
|
Fructose | 8 | 2024 | 284 | 2.330 |
Why?
|
Calcium Oxalate | 12 | 2023 | 75 | 2.300 |
Why?
|
Glomerular Filtration Rate | 36 | 2024 | 2227 | 2.120 |
Why?
|
Calcium | 30 | 2024 | 5792 | 2.110 |
Why?
|
Acetaminophen | 12 | 2022 | 549 | 2.020 |
Why?
|
Risk Factors | 203 | 2024 | 74886 | 1.880 |
Why?
|
Tinnitus | 4 | 2024 | 197 | 1.840 |
Why?
|
Diet | 36 | 2024 | 8089 | 1.770 |
Why?
|
Prospective Studies | 162 | 2024 | 54886 | 1.750 |
Why?
|
Alcoholic Beverages | 7 | 2014 | 266 | 1.720 |
Why?
|
Acute Kidney Injury | 10 | 2023 | 1946 | 1.640 |
Why?
|
Beverages | 13 | 2014 | 819 | 1.630 |
Why?
|
Self Report | 21 | 2024 | 3773 | 1.590 |
Why?
|
Hearing | 7 | 2023 | 504 | 1.590 |
Why?
|
Middle Aged | 304 | 2024 | 223233 | 1.570 |
Why?
|
Ascorbic Acid | 11 | 2015 | 658 | 1.510 |
Why?
|
Calcium, Dietary | 14 | 2022 | 533 | 1.500 |
Why?
|
Incidence | 100 | 2024 | 21526 | 1.480 |
Why?
|
Body Mass Index | 61 | 2023 | 13048 | 1.480 |
Why?
|
Coffee | 6 | 2021 | 594 | 1.450 |
Why?
|
Herpes Zoster | 3 | 2024 | 252 | 1.440 |
Why?
|
Adult | 278 | 2024 | 223317 | 1.430 |
Why?
|
Analgesics, Non-Narcotic | 9 | 2016 | 370 | 1.430 |
Why?
|
Kidney | 30 | 2021 | 7063 | 1.420 |
Why?
|
Kidney Failure, Chronic | 27 | 2018 | 2495 | 1.410 |
Why?
|
Nephrology | 5 | 2016 | 270 | 1.380 |
Why?
|
Cisplatin | 4 | 2020 | 1656 | 1.350 |
Why?
|
Spinal Fractures | 5 | 2022 | 710 | 1.340 |
Why?
|
Renal Insufficiency, Chronic | 11 | 2024 | 2299 | 1.340 |
Why?
|
Dietary Proteins | 14 | 2016 | 960 | 1.320 |
Why?
|
Sweetening Agents | 5 | 2013 | 290 | 1.320 |
Why?
|
Multivariate Analysis | 60 | 2020 | 12069 | 1.310 |
Why?
|
Hyperuricemia | 9 | 2017 | 221 | 1.280 |
Why?
|
Female | 329 | 2024 | 396660 | 1.270 |
Why?
|
Caffeine | 10 | 2014 | 703 | 1.270 |
Why?
|
Nurses | 26 | 2019 | 2501 | 1.260 |
Why?
|
Seafood | 6 | 2024 | 395 | 1.260 |
Why?
|
Alcohol Drinking | 20 | 2020 | 4045 | 1.260 |
Why?
|
Phosphorus | 7 | 2024 | 336 | 1.260 |
Why?
|
Coronary Disease | 17 | 2022 | 5914 | 1.240 |
Why?
|
Follow-Up Studies | 93 | 2024 | 39317 | 1.230 |
Why?
|
Postmenopause | 15 | 2018 | 2518 | 1.220 |
Why?
|
Creatinine | 33 | 2022 | 1916 | 1.220 |
Why?
|
Proportional Hazards Models | 44 | 2024 | 12536 | 1.210 |
Why?
|
Urinalysis | 11 | 2024 | 369 | 1.200 |
Why?
|
Aged | 202 | 2024 | 171319 | 1.190 |
Why?
|
Sodium Chloride Symporter Inhibitors | 4 | 2016 | 78 | 1.190 |
Why?
|
Humans | 436 | 2024 | 767040 | 1.170 |
Why?
|
Cohort Studies | 103 | 2024 | 41718 | 1.160 |
Why?
|
Life Style | 16 | 2020 | 3931 | 1.100 |
Why?
|
Sex Characteristics | 11 | 2024 | 2647 | 1.100 |
Why?
|
Nutrition Surveys | 16 | 2020 | 1738 | 1.090 |
Why?
|
Kidney Diseases | 16 | 2020 | 2099 | 1.080 |
Why?
|
Citric Acid | 9 | 2024 | 124 | 1.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 12 | 2022 | 2270 | 1.050 |
Why?
|
Urinary Incontinence | 15 | 2011 | 490 | 1.050 |
Why?
|
Histamine H2 Antagonists | 2 | 2018 | 169 | 1.040 |
Why?
|
Auditory Threshold | 4 | 2024 | 369 | 1.020 |
Why?
|
Risk | 42 | 2020 | 9606 | 1.010 |
Why?
|
Renin-Angiotensin System | 6 | 2020 | 736 | 1.000 |
Why?
|
Periodicals as Topic | 5 | 2016 | 1465 | 0.990 |
Why?
|
Proton Pump Inhibitors | 3 | 2022 | 551 | 0.930 |
Why?
|
Diphosphonates | 2 | 2021 | 633 | 0.930 |
Why?
|
Waist Circumference | 3 | 2019 | 935 | 0.920 |
Why?
|
Analgesics | 5 | 2022 | 1071 | 0.910 |
Why?
|
Vitamins | 9 | 2017 | 1639 | 0.910 |
Why?
|
Renal Insufficiency | 7 | 2009 | 812 | 0.860 |
Why?
|
Male | 228 | 2024 | 364203 | 0.860 |
Why?
|
Urolithiasis | 3 | 2024 | 123 | 0.850 |
Why?
|
Pravastatin | 7 | 2006 | 393 | 0.850 |
Why?
|
Aspirin | 11 | 2022 | 3135 | 0.830 |
Why?
|
Feeding Behavior | 12 | 2018 | 3207 | 0.820 |
Why?
|
Longitudinal Studies | 31 | 2024 | 14766 | 0.810 |
Why?
|
Dietary Supplements | 15 | 2024 | 3446 | 0.800 |
Why?
|
Diabetes Mellitus, Type 2 | 25 | 2024 | 12250 | 0.800 |
Why?
|
Renal Dialysis | 13 | 2014 | 1790 | 0.790 |
Why?
|
Hyponatremia | 3 | 2016 | 279 | 0.790 |
Why?
|
Cystitis, Interstitial | 4 | 2009 | 68 | 0.780 |
Why?
|
Diet, Mediterranean | 5 | 2022 | 746 | 0.780 |
Why?
|
Fish Oils | 2 | 2024 | 483 | 0.770 |
Why?
|
Risk Assessment | 40 | 2024 | 24299 | 0.770 |
Why?
|
United States | 103 | 2024 | 72971 | 0.760 |
Why?
|
Magnesium | 10 | 2024 | 815 | 0.750 |
Why?
|
Citrates | 4 | 2023 | 132 | 0.740 |
Why?
|
Cardiovascular Diseases | 29 | 2024 | 15645 | 0.720 |
Why?
|
Menopause | 7 | 2018 | 1655 | 0.720 |
Why?
|
Health Surveys | 21 | 2018 | 4056 | 0.710 |
Why?
|
Hearing Loss, Sensorineural | 3 | 2011 | 783 | 0.710 |
Why?
|
Vitamin D | 13 | 2017 | 3312 | 0.700 |
Why?
|
Motor Activity | 8 | 2014 | 2713 | 0.690 |
Why?
|
beta Carotene | 4 | 2015 | 523 | 0.690 |
Why?
|
Osteoporosis | 3 | 2021 | 1604 | 0.680 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 3 | 2019 | 347 | 0.670 |
Why?
|
Genetic Predisposition to Disease | 25 | 2023 | 18063 | 0.650 |
Why?
|
Estrogen Replacement Therapy | 6 | 2018 | 1209 | 0.650 |
Why?
|
Diabetic Nephropathies | 8 | 2009 | 974 | 0.640 |
Why?
|
Urinary Bladder Calculi | 1 | 2018 | 12 | 0.640 |
Why?
|
Carbonated Beverages | 3 | 2012 | 210 | 0.630 |
Why?
|
Sunburn | 1 | 2019 | 156 | 0.620 |
Why?
|
Weight Gain | 6 | 2019 | 2360 | 0.620 |
Why?
|
Angiotensinogen | 2 | 2009 | 161 | 0.610 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2009 | 153 | 0.600 |
Why?
|
Drinking | 4 | 2014 | 196 | 0.580 |
Why?
|
Psoriasis | 6 | 2012 | 925 | 0.570 |
Why?
|
Parathyroid Hormone | 8 | 2020 | 1804 | 0.570 |
Why?
|
Ultraviolet Rays | 2 | 2019 | 1101 | 0.570 |
Why?
|
Potassium | 9 | 2024 | 1314 | 0.560 |
Why?
|
Obesity | 22 | 2023 | 13085 | 0.560 |
Why?
|
Age Distribution | 18 | 2019 | 2870 | 0.550 |
Why?
|
Polymorphism, Single Nucleotide | 26 | 2021 | 16036 | 0.550 |
Why?
|
GABA-A Receptor Agonists | 1 | 2017 | 86 | 0.540 |
Why?
|
Sodium | 11 | 2024 | 1594 | 0.540 |
Why?
|
Calcium Phosphates | 1 | 2017 | 172 | 0.540 |
Why?
|
Snoring | 2 | 2022 | 211 | 0.530 |
Why?
|
Hip Fractures | 4 | 2022 | 997 | 0.520 |
Why?
|
Vitamin B 6 | 1 | 2017 | 237 | 0.520 |
Why?
|
Folic Acid | 4 | 2015 | 1336 | 0.510 |
Why?
|
Odds Ratio | 28 | 2017 | 9660 | 0.510 |
Why?
|
Furosemide | 2 | 2015 | 174 | 0.510 |
Why?
|
Fractures, Bone | 3 | 2017 | 2062 | 0.510 |
Why?
|
Pneumonia | 7 | 2010 | 2159 | 0.500 |
Why?
|
Ergocalciferols | 2 | 2017 | 110 | 0.500 |
Why?
|
Cross-Sectional Studies | 36 | 2024 | 26325 | 0.500 |
Why?
|
Sex Factors | 17 | 2023 | 10622 | 0.490 |
Why?
|
Skin Pigmentation | 1 | 2017 | 280 | 0.490 |
Why?
|
Community-Acquired Infections | 7 | 2010 | 470 | 0.480 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 158 | 0.480 |
Why?
|
Dairy Products | 4 | 2016 | 490 | 0.470 |
Why?
|
Sodium, Dietary | 9 | 2024 | 426 | 0.470 |
Why?
|
Hyperaldosteronism | 4 | 2018 | 252 | 0.470 |
Why?
|
Wrist Injuries | 1 | 2017 | 215 | 0.460 |
Why?
|
Time Factors | 36 | 2024 | 40154 | 0.460 |
Why?
|
Blood Pressure | 14 | 2018 | 8531 | 0.460 |
Why?
|
Allopurinol | 3 | 2024 | 202 | 0.460 |
Why?
|
Age Factors | 25 | 2018 | 18401 | 0.450 |
Why?
|
Audiometry | 4 | 2024 | 253 | 0.440 |
Why?
|
Bone Density | 2 | 2017 | 3573 | 0.440 |
Why?
|
Diabetes Complications | 3 | 2009 | 1319 | 0.430 |
Why?
|
Urine | 6 | 2018 | 362 | 0.430 |
Why?
|
Diet Surveys | 9 | 2017 | 1160 | 0.420 |
Why?
|
C-Reactive Protein | 11 | 2019 | 3851 | 0.420 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2019 | 1399 | 0.420 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2019 | 10748 | 0.410 |
Why?
|
Zinc | 1 | 2017 | 675 | 0.410 |
Why?
|
Meat | 4 | 2015 | 588 | 0.400 |
Why?
|
Vegetables | 6 | 2022 | 1199 | 0.400 |
Why?
|
Heavy Metal Poisoning, Nervous System | 1 | 2011 | 5 | 0.400 |
Why?
|
Bone Density Conservation Agents | 2 | 2017 | 797 | 0.400 |
Why?
|
Diuretics | 4 | 2020 | 614 | 0.400 |
Why?
|
Dietary Carbohydrates | 4 | 2014 | 896 | 0.390 |
Why?
|
Potassium, Dietary | 6 | 2024 | 103 | 0.390 |
Why?
|
Fibroblast Growth Factors | 3 | 2015 | 873 | 0.390 |
Why?
|
Genome-Wide Association Study | 23 | 2024 | 12790 | 0.390 |
Why?
|
Editorial Policies | 1 | 2016 | 458 | 0.390 |
Why?
|
Dietary Fats | 6 | 2014 | 2001 | 0.380 |
Why?
|
Kidney Function Tests | 7 | 2020 | 683 | 0.380 |
Why?
|
Genetic Loci | 8 | 2017 | 2629 | 0.380 |
Why?
|
Chi-Square Distribution | 9 | 2015 | 3431 | 0.380 |
Why?
|
Logistic Models | 26 | 2019 | 13284 | 0.380 |
Why?
|
Prevalence | 26 | 2020 | 15851 | 0.380 |
Why?
|
Audiometry, Pure-Tone | 4 | 2024 | 210 | 0.370 |
Why?
|
Hormone Replacement Therapy | 2 | 2009 | 756 | 0.370 |
Why?
|
Ibuprofen | 1 | 2012 | 228 | 0.360 |
Why?
|
Purines | 2 | 2005 | 614 | 0.360 |
Why?
|
Hormones | 1 | 2015 | 865 | 0.360 |
Why?
|
Yogurt | 3 | 2018 | 71 | 0.360 |
Why?
|
Interleukin-6 | 3 | 2019 | 3227 | 0.360 |
Why?
|
Birth Weight | 6 | 2020 | 2122 | 0.360 |
Why?
|
Smoking | 16 | 2017 | 9081 | 0.350 |
Why?
|
Hearing Tests | 2 | 2022 | 123 | 0.340 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2024 | 317 | 0.340 |
Why?
|
Mendelian Randomization Analysis | 5 | 2024 | 1040 | 0.340 |
Why?
|
Cholelithiasis | 1 | 2011 | 408 | 0.340 |
Why?
|
Myocardial Revascularization | 2 | 2013 | 795 | 0.340 |
Why?
|
Vitamin D Deficiency | 3 | 2017 | 1389 | 0.340 |
Why?
|
Epidemiologic Methods | 5 | 2009 | 1326 | 0.340 |
Why?
|
Hypercalciuria | 1 | 2009 | 31 | 0.340 |
Why?
|
Inosine | 3 | 2021 | 129 | 0.330 |
Why?
|
Linear Models | 10 | 2017 | 5875 | 0.320 |
Why?
|
Antihypertensive Agents | 6 | 2017 | 2030 | 0.320 |
Why?
|
Gastroesophageal Reflux | 1 | 2017 | 834 | 0.320 |
Why?
|
Fruit | 4 | 2011 | 1165 | 0.320 |
Why?
|
Energy Intake | 8 | 2018 | 2145 | 0.320 |
Why?
|
Drinking Behavior | 4 | 2012 | 102 | 0.320 |
Why?
|
Tea | 2 | 2007 | 289 | 0.310 |
Why?
|
Lipids | 5 | 2009 | 3322 | 0.310 |
Why?
|
Cost of Illness | 2 | 2017 | 1951 | 0.310 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2160 | 0.310 |
Why?
|
Carcinoma, Renal Cell | 4 | 2011 | 3186 | 0.300 |
Why?
|
Gemfibrozil | 2 | 2004 | 30 | 0.300 |
Why?
|
Cystatins | 2 | 2005 | 55 | 0.300 |
Why?
|
Diet Records | 2 | 2006 | 425 | 0.300 |
Why?
|
Drug Utilization | 2 | 2012 | 1190 | 0.300 |
Why?
|
Fatty Acids | 2 | 2007 | 1806 | 0.290 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2009 | 238 | 0.290 |
Why?
|
Body Weight | 8 | 2012 | 4627 | 0.290 |
Why?
|
Pyridoxine | 2 | 1999 | 108 | 0.290 |
Why?
|
Mass Screening | 5 | 2020 | 5456 | 0.280 |
Why?
|
Case-Control Studies | 25 | 2023 | 22254 | 0.280 |
Why?
|
Public Policy | 1 | 2011 | 551 | 0.280 |
Why?
|
Probenecid | 2 | 2017 | 72 | 0.280 |
Why?
|
Myocardial Infarction | 11 | 2013 | 11513 | 0.280 |
Why?
|
Stroke | 8 | 2022 | 9746 | 0.270 |
Why?
|
Severity of Illness Index | 16 | 2021 | 15925 | 0.270 |
Why?
|
Rheumatic Diseases | 2 | 2022 | 659 | 0.270 |
Why?
|
Forecasting | 1 | 2015 | 2936 | 0.270 |
Why?
|
Patient Preference | 1 | 2014 | 947 | 0.270 |
Why?
|
Health Personnel | 14 | 2018 | 3387 | 0.270 |
Why?
|
Adrenalectomy | 2 | 2018 | 347 | 0.260 |
Why?
|
Women's Health | 6 | 2017 | 2082 | 0.260 |
Why?
|
Inflammation | 3 | 2019 | 10869 | 0.260 |
Why?
|
Comorbidity | 10 | 2018 | 10582 | 0.260 |
Why?
|
Neoplasms | 4 | 2023 | 22350 | 0.260 |
Why?
|
Sulfates | 4 | 2016 | 379 | 0.250 |
Why?
|
Exercise | 7 | 2018 | 5954 | 0.250 |
Why?
|
Taste Perception | 2 | 2018 | 38 | 0.250 |
Why?
|
Endothelium, Vascular | 3 | 2016 | 4424 | 0.250 |
Why?
|
Vitamin A | 4 | 2015 | 611 | 0.250 |
Why?
|
Phosphates | 5 | 2016 | 765 | 0.250 |
Why?
|
Arthritis, Rheumatoid | 5 | 2021 | 3778 | 0.250 |
Why?
|
Waist-Hip Ratio | 4 | 2023 | 520 | 0.250 |
Why?
|
Aging | 5 | 2020 | 8729 | 0.240 |
Why?
|
Body Size | 3 | 2017 | 462 | 0.240 |
Why?
|
Circadian Rhythm | 3 | 2016 | 2591 | 0.240 |
Why?
|
Food, Fortified | 2 | 2015 | 189 | 0.240 |
Why?
|
Benzbromarone | 1 | 2024 | 7 | 0.240 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 1999 | 519 | 0.240 |
Why?
|
Uricosuric Agents | 3 | 2024 | 30 | 0.240 |
Why?
|
Nephrocalcinosis | 1 | 2005 | 51 | 0.240 |
Why?
|
Gout Suppressants | 2 | 2024 | 176 | 0.240 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2024 | 2478 | 0.230 |
Why?
|
Aged, 80 and over | 23 | 2020 | 59548 | 0.230 |
Why?
|
Antioxidants | 4 | 2008 | 1671 | 0.230 |
Why?
|
Triglycerides | 3 | 2009 | 2444 | 0.230 |
Why?
|
Anemia | 3 | 2003 | 1514 | 0.230 |
Why?
|
Hyperoxaluria | 2 | 2020 | 33 | 0.230 |
Why?
|
Prediabetic State | 1 | 2010 | 547 | 0.230 |
Why?
|
Micronutrients | 1 | 2007 | 390 | 0.220 |
Why?
|
Cholesterol | 7 | 2016 | 2905 | 0.220 |
Why?
|
Nutritional Status | 3 | 2012 | 1628 | 0.220 |
Why?
|
Sucrose | 1 | 2024 | 156 | 0.220 |
Why?
|
Confidence Intervals | 8 | 2009 | 2920 | 0.220 |
Why?
|
Aldosterone | 2 | 2020 | 881 | 0.220 |
Why?
|
Health Status Indicators | 2 | 2009 | 969 | 0.220 |
Why?
|
Carotenoids | 1 | 2006 | 620 | 0.220 |
Why?
|
Ureteral Calculi | 1 | 2004 | 111 | 0.220 |
Why?
|
Genetic Pleiotropy | 1 | 2024 | 181 | 0.210 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2004 | 124 | 0.210 |
Why?
|
Naphthalenes | 1 | 2004 | 198 | 0.210 |
Why?
|
Abortifacient Agents | 1 | 2022 | 11 | 0.210 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2016 | 164 | 0.210 |
Why?
|
Prognosis | 14 | 2024 | 29963 | 0.210 |
Why?
|
Disease Progression | 9 | 2021 | 13646 | 0.200 |
Why?
|
Terminology as Topic | 1 | 2010 | 1540 | 0.200 |
Why?
|
Vitamin E | 3 | 2015 | 872 | 0.200 |
Why?
|
Vasodilation | 2 | 2016 | 968 | 0.200 |
Why?
|
Parity | 3 | 2011 | 931 | 0.200 |
Why?
|
Gene Frequency | 7 | 2017 | 3621 | 0.200 |
Why?
|
Parkinson Disease | 4 | 2021 | 2886 | 0.200 |
Why?
|
Fluid Therapy | 1 | 2006 | 587 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2017 | 3249 | 0.200 |
Why?
|
Urinary Incontinence, Stress | 5 | 2011 | 180 | 0.200 |
Why?
|
Free Radical Scavengers | 1 | 2003 | 213 | 0.190 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2004 | 360 | 0.190 |
Why?
|
Bicarbonates | 2 | 2013 | 293 | 0.190 |
Why?
|
Wine | 3 | 2014 | 172 | 0.190 |
Why?
|
Hypercholesterolemia | 3 | 2010 | 1144 | 0.190 |
Why?
|
Hypertension, Renal | 1 | 2001 | 135 | 0.190 |
Why?
|
Acetylcysteine | 1 | 2003 | 262 | 0.190 |
Why?
|
Regression Analysis | 9 | 2024 | 6331 | 0.190 |
Why?
|
Oxo-Acid-Lyases | 1 | 2020 | 23 | 0.180 |
Why?
|
Diabetic Angiopathies | 3 | 2012 | 806 | 0.180 |
Why?
|
Fabry Disease | 1 | 2021 | 89 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3464 | 0.180 |
Why?
|
Adiponectin | 1 | 2007 | 1115 | 0.180 |
Why?
|
Renin | 3 | 2018 | 647 | 0.180 |
Why?
|
Immune System Diseases | 1 | 2022 | 253 | 0.170 |
Why?
|
Cystinuria | 1 | 2020 | 22 | 0.170 |
Why?
|
Metabolome | 2 | 2024 | 1008 | 0.170 |
Why?
|
Oxalobacter formigenes | 2 | 2011 | 2 | 0.170 |
Why?
|
Homocysteine | 4 | 2009 | 637 | 0.170 |
Why?
|
Phenotype | 7 | 2024 | 16718 | 0.170 |
Why?
|
Pre-Eclampsia | 2 | 1999 | 1255 | 0.170 |
Why?
|
Contrast Media | 2 | 2023 | 5329 | 0.170 |
Why?
|
Sex Distribution | 6 | 2012 | 2276 | 0.170 |
Why?
|
Albumins | 1 | 2002 | 577 | 0.170 |
Why?
|
Contraceptives, Oral | 2 | 1999 | 560 | 0.170 |
Why?
|
Hemoglobins | 2 | 2002 | 1531 | 0.160 |
Why?
|
Hematocrit | 1 | 2001 | 622 | 0.160 |
Why?
|
Mercury | 2 | 2012 | 289 | 0.160 |
Why?
|
Wisconsin | 1 | 2019 | 122 | 0.160 |
Why?
|
Carcinoma, Basal Cell | 2 | 2017 | 565 | 0.160 |
Why?
|
Data Collection | 6 | 2023 | 3321 | 0.160 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 102 | 0.160 |
Why?
|
Hypoparathyroidism | 1 | 2020 | 136 | 0.160 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2006 | 1515 | 0.160 |
Why?
|
Choice Behavior | 1 | 2005 | 848 | 0.160 |
Why?
|
Health Occupations | 1 | 2020 | 226 | 0.160 |
Why?
|
Double-Blind Method | 11 | 2021 | 12451 | 0.160 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2020 | 111 | 0.160 |
Why?
|
Central Nervous System Stimulants | 1 | 2007 | 1168 | 0.150 |
Why?
|
Hearing Aids | 1 | 2019 | 58 | 0.150 |
Why?
|
Taste Disorders | 1 | 2018 | 37 | 0.150 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 279 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1712 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 3 | 2023 | 20741 | 0.150 |
Why?
|
Acids | 2 | 2016 | 125 | 0.150 |
Why?
|
Metabolomics | 2 | 2024 | 1675 | 0.150 |
Why?
|
Diet, Fat-Restricted | 1 | 2020 | 328 | 0.150 |
Why?
|
Olfactory Perception | 1 | 2018 | 64 | 0.150 |
Why?
|
Genotype | 10 | 2019 | 13035 | 0.150 |
Why?
|
Patient Compliance | 3 | 2020 | 2697 | 0.140 |
Why?
|
Suntan | 1 | 2017 | 17 | 0.140 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4247 | 0.140 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2020 | 263 | 0.140 |
Why?
|
Sleep | 4 | 2022 | 4816 | 0.140 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1999 | 184 | 0.140 |
Why?
|
Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
Young Adult | 15 | 2020 | 59980 | 0.140 |
Why?
|
Insulin | 2 | 2009 | 6602 | 0.140 |
Why?
|
Iron | 2 | 2002 | 1811 | 0.140 |
Why?
|
Taste | 1 | 2018 | 190 | 0.140 |
Why?
|
Fishes | 3 | 2019 | 607 | 0.140 |
Why?
|
Hair Color | 1 | 2017 | 131 | 0.140 |
Why?
|
Dietary Sucrose | 3 | 2012 | 242 | 0.130 |
Why?
|
Renal Circulation | 1 | 2017 | 288 | 0.130 |
Why?
|
Hospitalization | 5 | 2024 | 10815 | 0.130 |
Why?
|
Trace Elements | 1 | 2018 | 193 | 0.130 |
Why?
|
Adiposity | 2 | 2023 | 1894 | 0.130 |
Why?
|
Recurrence | 4 | 2024 | 8504 | 0.130 |
Why?
|
Melatonin | 2 | 2013 | 670 | 0.130 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2020 | 1897 | 0.130 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2017 | 167 | 0.130 |
Why?
|
Smell | 1 | 2018 | 259 | 0.130 |
Why?
|
Nursing Staff | 1 | 2017 | 113 | 0.130 |
Why?
|
Beer | 2 | 2014 | 135 | 0.130 |
Why?
|
Secondary Prevention | 2 | 2016 | 1472 | 0.130 |
Why?
|
Claudins | 2 | 2013 | 116 | 0.130 |
Why?
|
Hyperparathyroidism | 1 | 2017 | 339 | 0.130 |
Why?
|
Nutrition Assessment | 3 | 2012 | 740 | 0.130 |
Why?
|
Electrolytes | 1 | 2016 | 279 | 0.130 |
Why?
|
Retrospective Studies | 21 | 2024 | 81659 | 0.130 |
Why?
|
Premenopause | 2 | 2018 | 1039 | 0.130 |
Why?
|
Olfaction Disorders | 1 | 2018 | 225 | 0.130 |
Why?
|
Cause of Death | 6 | 2022 | 3717 | 0.130 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2010 | 1132 | 0.130 |
Why?
|
ROC Curve | 3 | 2021 | 3618 | 0.130 |
Why?
|
Oxalic Acid | 2 | 2016 | 20 | 0.120 |
Why?
|
Rheumatology | 1 | 2021 | 617 | 0.120 |
Why?
|
Treatment Outcome | 18 | 2024 | 65295 | 0.120 |
Why?
|
Preventive Medicine | 1 | 2017 | 246 | 0.120 |
Why?
|
Group Processes | 1 | 2016 | 225 | 0.120 |
Why?
|
Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.120 |
Why?
|
Minerals | 1 | 2016 | 279 | 0.120 |
Why?
|
Dyssomnias | 1 | 2014 | 28 | 0.120 |
Why?
|
Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
Probability | 5 | 2010 | 2476 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13650 | 0.120 |
Why?
|
Fatty Acids, Omega-6 | 2 | 2007 | 225 | 0.120 |
Why?
|
Graft Survival | 3 | 2020 | 3896 | 0.120 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2016 | 457 | 0.120 |
Why?
|
Insulin Resistance | 4 | 2020 | 3986 | 0.110 |
Why?
|
Earthquakes | 1 | 2017 | 192 | 0.110 |
Why?
|
Diet, Sodium-Restricted | 2 | 2020 | 291 | 0.110 |
Why?
|
Genetic Variation | 3 | 2017 | 6611 | 0.110 |
Why?
|
Urinary Incontinence, Urge | 3 | 2011 | 50 | 0.110 |
Why?
|
Kidney Neoplasms | 2 | 2011 | 4282 | 0.110 |
Why?
|
Apolipoproteins E | 1 | 2019 | 1459 | 0.110 |
Why?
|
Cognition | 3 | 2019 | 7059 | 0.110 |
Why?
|
Peer Review, Research | 1 | 2016 | 343 | 0.110 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 344 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
Colorimetry | 2 | 2011 | 147 | 0.110 |
Why?
|
Interpersonal Relations | 2 | 2016 | 1432 | 0.110 |
Why?
|
Deafness | 1 | 2017 | 460 | 0.100 |
Why?
|
Public Health | 1 | 2006 | 2681 | 0.100 |
Why?
|
Primary Prevention | 1 | 2020 | 1188 | 0.100 |
Why?
|
Alleles | 6 | 2019 | 6893 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 677 | 0.100 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15424 | 0.100 |
Why?
|
Phenols | 1 | 2016 | 526 | 0.100 |
Why?
|
Chronic Disease | 5 | 2020 | 9362 | 0.100 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4855 | 0.100 |
Why?
|
Radioimmunoassay | 2 | 2016 | 861 | 0.100 |
Why?
|
Adolescent | 13 | 2024 | 89046 | 0.100 |
Why?
|
Cooking | 1 | 2014 | 327 | 0.100 |
Why?
|
Prescriptions | 1 | 2014 | 388 | 0.100 |
Why?
|
Methylmercury Compounds | 1 | 2012 | 103 | 0.090 |
Why?
|
Boston | 5 | 2022 | 9360 | 0.090 |
Why?
|
Phosphorus, Dietary | 1 | 2010 | 20 | 0.090 |
Why?
|
Creatine | 2 | 2011 | 424 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2017 | 684 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor | 4 | 2010 | 588 | 0.090 |
Why?
|
Coronary Angiography | 1 | 2003 | 4525 | 0.090 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2012 | 320 | 0.090 |
Why?
|
Proteinuria | 3 | 2017 | 613 | 0.090 |
Why?
|
Disasters | 1 | 2017 | 521 | 0.090 |
Why?
|
Leisure Activities | 1 | 2012 | 310 | 0.090 |
Why?
|
Sarcopenia | 1 | 2016 | 378 | 0.090 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2008 | 336 | 0.090 |
Why?
|
Hyperphosphatemia | 1 | 2010 | 38 | 0.090 |
Why?
|
Health Behavior | 4 | 2015 | 2650 | 0.090 |
Why?
|
Infant, Low Birth Weight | 1 | 2015 | 871 | 0.090 |
Why?
|
Cadmium | 1 | 2011 | 218 | 0.090 |
Why?
|
Hyperthyroidism | 1 | 2012 | 292 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Cystatin C | 3 | 2010 | 272 | 0.090 |
Why?
|
Tooth Loss | 1 | 2012 | 198 | 0.090 |
Why?
|
Kidney Transplantation | 3 | 2020 | 4268 | 0.090 |
Why?
|
Reference Values | 2 | 2008 | 4918 | 0.090 |
Why?
|
Hyperlipidemias | 2 | 2005 | 771 | 0.080 |
Why?
|
Skin Neoplasms | 3 | 2017 | 5859 | 0.080 |
Why?
|
Medical Records | 3 | 2006 | 1409 | 0.080 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2011 | 119 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1502 | 0.080 |
Why?
|
Benzhydryl Compounds | 1 | 2016 | 944 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1433 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2011 | 361 | 0.080 |
Why?
|
Television | 1 | 2012 | 409 | 0.080 |
Why?
|
Acid-Base Imbalance | 1 | 2009 | 41 | 0.080 |
Why?
|
Resistin | 1 | 2010 | 172 | 0.080 |
Why?
|
Lactation | 1 | 2011 | 392 | 0.080 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2016 | 392 | 0.080 |
Why?
|
Glaucoma, Open-Angle | 1 | 2016 | 742 | 0.080 |
Why?
|
Milk | 2 | 2018 | 437 | 0.080 |
Why?
|
Lead Poisoning | 1 | 2011 | 323 | 0.080 |
Why?
|
Dietary Fiber | 1 | 2013 | 767 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20169 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2011 | 222 | 0.080 |
Why?
|
Research Design | 1 | 2004 | 6210 | 0.080 |
Why?
|
Phytotherapy | 1 | 2010 | 298 | 0.080 |
Why?
|
Mental Health | 1 | 2003 | 3272 | 0.080 |
Why?
|
Hypotension | 1 | 2014 | 888 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1626 | 0.080 |
Why?
|
Algorithms | 3 | 2024 | 14098 | 0.080 |
Why?
|
Periodontal Diseases | 1 | 2012 | 454 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2020 | 2085 | 0.080 |
Why?
|
Prolactin | 1 | 2010 | 627 | 0.070 |
Why?
|
Arsenic | 1 | 2011 | 357 | 0.070 |
Why?
|
Demography | 2 | 2011 | 1641 | 0.070 |
Why?
|
Hypothyroidism | 1 | 2013 | 667 | 0.070 |
Why?
|
Survival Rate | 6 | 2020 | 12823 | 0.070 |
Why?
|
Graft Rejection | 2 | 2020 | 4498 | 0.070 |
Why?
|
Ambulatory Care Facilities | 1 | 2014 | 939 | 0.070 |
Why?
|
Air Pollution | 1 | 2022 | 2378 | 0.070 |
Why?
|
Air Pollutants | 1 | 2022 | 2920 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.070 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2009 | 190 | 0.070 |
Why?
|
Work Schedule Tolerance | 1 | 2012 | 553 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2010 | 299 | 0.070 |
Why?
|
Sodium Chloride, Dietary | 1 | 2010 | 300 | 0.070 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2009 | 414 | 0.070 |
Why?
|
Diabetes Mellitus | 3 | 2006 | 5886 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2016 | 1202 | 0.070 |
Why?
|
Flavonoids | 1 | 2010 | 447 | 0.070 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2744 | 0.070 |
Why?
|
Linoleic Acid | 2 | 2005 | 158 | 0.070 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2010 | 291 | 0.070 |
Why?
|
China | 3 | 2018 | 2394 | 0.070 |
Why?
|
Plant Extracts | 1 | 2010 | 496 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2428 | 0.070 |
Why?
|
Urodynamics | 2 | 2009 | 349 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2009 | 861 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2850 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 2010 | 988 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2020 | 10393 | 0.060 |
Why?
|
Italy | 2 | 2020 | 856 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.060 |
Why?
|
Cholesterol, HDL | 4 | 2004 | 1816 | 0.060 |
Why?
|
Lead | 1 | 2011 | 882 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7121 | 0.060 |
Why?
|
Morbidity | 1 | 2011 | 1754 | 0.060 |
Why?
|
Heart Failure | 3 | 2013 | 11877 | 0.060 |
Why?
|
Child | 6 | 2020 | 80771 | 0.060 |
Why?
|
Veterinarians | 1 | 2005 | 13 | 0.060 |
Why?
|
Laos | 1 | 2004 | 27 | 0.060 |
Why?
|
Brachial Artery | 2 | 2016 | 373 | 0.060 |
Why?
|
Eating | 2 | 2013 | 1541 | 0.060 |
Why?
|
Computational Biology | 1 | 2017 | 3567 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1188 | 0.060 |
Why?
|
Chromium Compounds | 1 | 2004 | 7 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 828 | 0.060 |
Why?
|
Urinary Calculi | 1 | 2005 | 81 | 0.060 |
Why?
|
Ultrasonography | 2 | 2016 | 6000 | 0.060 |
Why?
|
Zebrafish | 2 | 2016 | 3036 | 0.060 |
Why?
|
Phytic Acid | 1 | 2004 | 22 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2538 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1733 | 0.060 |
Why?
|
Publishing | 1 | 2011 | 837 | 0.060 |
Why?
|
Mexican Americans | 2 | 2002 | 165 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4522 | 0.060 |
Why?
|
Hyperhomocysteinemia | 1 | 2004 | 117 | 0.060 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2005 | 222 | 0.060 |
Why?
|
Minnesota | 1 | 2004 | 339 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6067 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3804 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 258 | 0.060 |
Why?
|
Ovariectomy | 3 | 2018 | 612 | 0.050 |
Why?
|
Alberta | 2 | 2013 | 67 | 0.050 |
Why?
|
Dentists | 1 | 2005 | 176 | 0.050 |
Why?
|
Arachidonic Acid | 1 | 2005 | 430 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2011 | 2592 | 0.050 |
Why?
|
Biological Availability | 1 | 2004 | 387 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 692 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2257 | 0.050 |
Why?
|
Breast Feeding | 1 | 2011 | 1362 | 0.050 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 428 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2011 | 1939 | 0.050 |
Why?
|
Environmental Exposure | 2 | 2022 | 4546 | 0.050 |
Why?
|
Animals | 12 | 2019 | 168965 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2016 | 3001 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7469 | 0.050 |
Why?
|
Pharmacists | 1 | 2005 | 261 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2887 | 0.050 |
Why?
|
Estrone | 1 | 2003 | 234 | 0.050 |
Why?
|
Metals | 1 | 2007 | 711 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4780 | 0.050 |
Why?
|
Republic of Korea | 1 | 2024 | 591 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3964 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4903 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2815 | 0.050 |
Why?
|
Transferrin | 1 | 2002 | 283 | 0.050 |
Why?
|
Heart Rate | 1 | 2013 | 4209 | 0.050 |
Why?
|
Chlorides | 1 | 2004 | 666 | 0.050 |
Why?
|
Nephelometry and Turbidimetry | 2 | 2012 | 91 | 0.050 |
Why?
|
Urination Disorders | 1 | 2002 | 236 | 0.050 |
Why?
|
Calcinosis | 1 | 2009 | 1481 | 0.050 |
Why?
|
Hydroxycholecalciferols | 1 | 2020 | 44 | 0.050 |
Why?
|
Office Visits | 1 | 2005 | 595 | 0.040 |
Why?
|
Systole | 1 | 2003 | 935 | 0.040 |
Why?
|
Quality of Life | 2 | 2012 | 13485 | 0.040 |
Why?
|
Nitrates | 1 | 2022 | 259 | 0.040 |
Why?
|
Diastole | 1 | 2003 | 784 | 0.040 |
Why?
|
Urea | 2 | 2013 | 448 | 0.040 |
Why?
|
Population Surveillance | 1 | 2011 | 2594 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 373 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2005 | 488 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3702 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2006 | 935 | 0.040 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 709 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2004 | 609 | 0.040 |
Why?
|
Cystine | 1 | 2020 | 96 | 0.040 |
Why?
|
Southeastern United States | 1 | 1999 | 93 | 0.040 |
Why?
|
Ferritins | 1 | 2002 | 601 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5180 | 0.040 |
Why?
|
Documentation | 1 | 2006 | 915 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 6001 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2004 | 937 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4054 | 0.040 |
Why?
|
Pregnancy | 6 | 2017 | 30238 | 0.040 |
Why?
|
Parturition | 1 | 2003 | 454 | 0.040 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 409 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2127 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4881 | 0.040 |
Why?
|
Calcitriol | 1 | 2020 | 303 | 0.040 |
Why?
|
Water-Electrolyte Balance | 1 | 2020 | 326 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2002 | 793 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2002 | 996 | 0.040 |
Why?
|
Taste Buds | 1 | 2018 | 23 | 0.040 |
Why?
|
Cheese | 1 | 2018 | 39 | 0.040 |
Why?
|
Consensus | 2 | 2020 | 3207 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2009 | 3114 | 0.040 |
Why?
|
Israel | 1 | 2020 | 726 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2005 | 969 | 0.040 |
Why?
|
Hysterectomy | 2 | 2018 | 863 | 0.040 |
Why?
|
Research Support as Topic | 1 | 2002 | 697 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2022 | 467 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 3968 | 0.040 |
Why?
|
Brain | 1 | 2024 | 27163 | 0.040 |
Why?
|
Olfactory Receptor Neurons | 1 | 2018 | 95 | 0.040 |
Why?
|
Renal Plasma Flow | 1 | 2017 | 27 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1253 | 0.040 |
Why?
|
Glucose | 2 | 2024 | 4341 | 0.040 |
Why?
|
Headache | 1 | 2005 | 1261 | 0.040 |
Why?
|
Reference Standards | 2 | 2012 | 1011 | 0.040 |
Why?
|
Absorption | 1 | 1997 | 243 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2020 | 487 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36582 | 0.030 |
Why?
|
Immunoassay | 2 | 2012 | 744 | 0.030 |
Why?
|
Body Height | 2 | 2004 | 1565 | 0.030 |
Why?
|
Captopril | 1 | 2017 | 261 | 0.030 |
Why?
|
Specimen Handling | 2 | 2012 | 706 | 0.030 |
Why?
|
Registries | 1 | 2012 | 8351 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30211 | 0.030 |
Why?
|
Estrogens | 1 | 2003 | 1536 | 0.030 |
Why?
|
Methotrexate | 1 | 2022 | 1718 | 0.030 |
Why?
|
Estradiol | 1 | 2003 | 1951 | 0.030 |
Why?
|
Maine | 1 | 2016 | 146 | 0.030 |
Why?
|
Nuclear Family | 1 | 1996 | 311 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2012 | 7868 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2200 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4049 | 0.030 |
Why?
|
Overweight | 2 | 2017 | 2448 | 0.030 |
Why?
|
Crystallization | 1 | 2016 | 518 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2658 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 253 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1422 | 0.030 |
Why?
|
Acidosis | 1 | 2016 | 271 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2016 | 463 | 0.030 |
Why?
|
Massachusetts | 3 | 2009 | 8890 | 0.030 |
Why?
|
Angiotensin II | 1 | 2017 | 842 | 0.030 |
Why?
|
Models, Statistical | 2 | 2006 | 5098 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6310 | 0.030 |
Why?
|
Drug Evaluation | 2 | 2006 | 641 | 0.030 |
Why?
|
Europe | 2 | 2011 | 3432 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1006 | 0.030 |
Why?
|
Buffers | 1 | 2013 | 141 | 0.030 |
Why?
|
Body Composition | 1 | 2003 | 2454 | 0.030 |
Why?
|
Practice Guidelines as Topic | 3 | 2012 | 7435 | 0.030 |
Why?
|
Spine | 1 | 2020 | 1139 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2007 | 5345 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6215 | 0.030 |
Why?
|
Vasculitis | 1 | 1997 | 526 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 646 | 0.030 |
Why?
|
Depression | 1 | 2013 | 8234 | 0.030 |
Why?
|
Inhibin-beta Subunits | 1 | 2012 | 27 | 0.030 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2012 | 35 | 0.030 |
Why?
|
Insurance, Health | 1 | 2005 | 2519 | 0.030 |
Why?
|
Lipid Metabolism | 2 | 2016 | 1895 | 0.030 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 106 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5702 | 0.030 |
Why?
|
Area Under Curve | 2 | 2008 | 1639 | 0.030 |
Why?
|
Inpatients | 1 | 2024 | 2563 | 0.020 |
Why?
|
Health Expenditures | 1 | 2005 | 2390 | 0.020 |
Why?
|
Inhibins | 1 | 2012 | 210 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1998 | 1155 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 326 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 1997 | 963 | 0.020 |
Why?
|
Caspase 9 | 1 | 2012 | 184 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2002 | 2783 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 367 | 0.020 |
Why?
|
Phthalic Acids | 1 | 2016 | 487 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2013 | 386 | 0.020 |
Why?
|
Nursing Methodology Research | 1 | 2011 | 64 | 0.020 |
Why?
|
Vaccinium | 1 | 2010 | 2 | 0.020 |
Why?
|
Statistics as Topic | 2 | 2009 | 2350 | 0.020 |
Why?
|
Apigenin | 1 | 2010 | 16 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3108 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2012 | 205 | 0.020 |
Why?
|
Fragaria | 1 | 2010 | 21 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1997 | 836 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6507 | 0.020 |
Why?
|
Anthocyanins | 1 | 2010 | 80 | 0.020 |
Why?
|
Catechin | 1 | 2010 | 70 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2001 | 2780 | 0.020 |
Why?
|
Appetite | 1 | 2012 | 247 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2014 | 606 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 325 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 935 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2011 | 384 | 0.020 |
Why?
|
Amine Oxidase (Copper-Containing) | 1 | 2010 | 41 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 14672 | 0.020 |
Why?
|
Single-Blind Method | 2 | 2004 | 1587 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2018 | 15824 | 0.020 |
Why?
|
Particulate Matter | 1 | 2022 | 2621 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2011 | 208 | 0.020 |
Why?
|
Asia | 1 | 2011 | 629 | 0.020 |
Why?
|
Computer Simulation | 1 | 2023 | 6260 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2931 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23621 | 0.020 |
Why?
|
Serum Albumin | 1 | 2012 | 676 | 0.020 |
Why?
|
Africa | 1 | 2011 | 725 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2012 | 385 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 416 | 0.020 |
Why?
|
C-Peptide | 1 | 2011 | 443 | 0.020 |
Why?
|
Time | 1 | 2010 | 551 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2716 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2011 | 221 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4026 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26396 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2008 | 291 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2012 | 661 | 0.020 |
Why?
|
Quality Control | 1 | 2011 | 835 | 0.020 |
Why?
|
Noise | 1 | 2010 | 295 | 0.020 |
Why?
|
E-Selectin | 1 | 2010 | 576 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2013 | 1008 | 0.020 |
Why?
|
Nursing Research | 1 | 2008 | 79 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1604 | 0.020 |
Why?
|
Databases, Factual | 3 | 2010 | 8068 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2007 | 208 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 976 | 0.020 |
Why?
|
Physicians | 1 | 2005 | 4593 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1999 | 2186 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 854 | 0.020 |
Why?
|
Logical Observation Identifiers Names and Codes | 1 | 2006 | 16 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8535 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2013 | 1758 | 0.020 |
Why?
|
Renal Replacement Therapy | 1 | 2008 | 281 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2105 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2008 | 217 | 0.020 |
Why?
|
Hospital Records | 1 | 2006 | 93 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2005 | 6966 | 0.020 |
Why?
|
Forms and Records Control | 1 | 2006 | 158 | 0.020 |
Why?
|
Insurance Claim Reporting | 1 | 2006 | 166 | 0.020 |
Why?
|
Pain | 1 | 2000 | 5101 | 0.020 |
Why?
|
Patient Care Team | 1 | 2016 | 2516 | 0.020 |
Why?
|
alpha-Linolenic Acid | 1 | 2005 | 144 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5519 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 996 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2010 | 1666 | 0.010 |
Why?
|
Asthma | 1 | 2004 | 6268 | 0.010 |
Why?
|
Infant | 2 | 2008 | 36485 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 2131 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2189 | 0.010 |
Why?
|
Models, Biological | 1 | 2001 | 9464 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 2006 | 445 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2011 | 1969 | 0.010 |
Why?
|
Seasons | 1 | 2010 | 1523 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
Apolipoprotein B-100 | 1 | 2004 | 157 | 0.010 |
Why?
|
Child, Preschool | 2 | 2008 | 42606 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2902 | 0.010 |
Why?
|
Genome, Human | 1 | 2017 | 4441 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 319 | 0.010 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1883 | 0.010 |
Why?
|
Genetic Markers | 1 | 2010 | 2602 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 1612 | 0.010 |
Why?
|
Thiamine | 1 | 2004 | 160 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2722 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2429 | 0.010 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7848 | 0.010 |
Why?
|
Apolipoproteins B | 1 | 2004 | 385 | 0.010 |
Why?
|
Edetic Acid | 1 | 2003 | 277 | 0.010 |
Why?
|
Survival Analysis | 2 | 2005 | 10092 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2011 | 2487 | 0.010 |
Why?
|
Memory | 1 | 2012 | 2192 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2004 | 529 | 0.010 |
Why?
|
Fibrinogen | 1 | 2005 | 892 | 0.010 |
Why?
|
Emotions | 1 | 2013 | 2760 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12414 | 0.010 |
Why?
|
Phenacetin | 1 | 2000 | 14 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2003 | 683 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 2002 | 238 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5796 | 0.010 |
Why?
|
Clinical Medicine | 1 | 2002 | 145 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6513 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3445 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2000 | 213 | 0.010 |
Why?
|
Health Status | 1 | 2012 | 4091 | 0.010 |
Why?
|
Postoperative Care | 1 | 2006 | 1480 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2381 | 0.010 |
Why?
|
Fasting | 1 | 2004 | 1607 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2909 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11923 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2004 | 1721 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12793 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2013 | 3418 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14476 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 4838 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1998 | 11097 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2004 | 2392 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9532 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8628 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9612 | 0.010 |
Why?
|
Drug Combinations | 1 | 2000 | 2086 | 0.010 |
Why?
|
Prostatectomy | 1 | 2002 | 1786 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22361 | 0.010 |
Why?
|
Diabetic Retinopathy | 1 | 2003 | 1300 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2005 | 4560 | 0.010 |
Why?
|
Necrosis | 1 | 1997 | 1614 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12158 | 0.010 |
Why?
|
Water | 1 | 1999 | 1419 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 6489 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2011 | 6573 | 0.010 |
Why?
|
Mice | 1 | 2012 | 81912 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1997 | 12986 | 0.000 |
Why?
|